Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
19.7%
% of XLV's 61 holdings also in PJP
40.0%
% of PJP's 30 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.3% | 5.5% | 5.5% |
|
ABBVIE INC | 6.1% | 5.1% | 5.1% |
|
MERCK & CO. INC. | 4.9% | 5.1% | 4.9% |
|
JOHNSON & JOHNSON | 6.7% | 4.7% | 4.7% |
|
ABBOTT LABORATORIES | 3.8% | 4.9% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PJP
|
UNITEDHEALTH GROUP INC | 9.4% |
|
ELI LILLY & CO | 6.9% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
INTUITIVE SURGICAL INC | 3.8% |
|
DANAHER CORP | 3.0% |
|
BOSTON SCIENTIFIC CORP | 2.7% |
|
STRYKER CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
 |
MEDTRONIC PLC | 2.0% |
|
JOHNSON & JOHNSON | 2.0% |
XLV Underweight Relative to PJP
|
TARSUS PHARMACEUTICALS, INC. | -3.1% |
|
LIQUIDIA TECHNOLOGIES, INC. | -3.1% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.0% |
|
SUPERNUS PHARMACEUTICALS INC | -2.9% |
|
TRAVERE THERAPEUTICS, INC. | -2.8% |
|
UNITED THERAPEUTICS CORP | -2.8% |
|
JAZZ PHARMACEUTICALS PLC | -2.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.7% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.7% |